Table 1 Summary of studies included in the meta-analysis
Author | Region | Design | Year | Study Period | Sample size | Indications | Conversion n (%) | ITT | ISGPF | Clavien–Dindo | Mortality | Quality scores | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LPD | OPD | ||||||||||||
Croome | USA | OCS (P,S) | 2014 | 2008–2013 | 108 | 214 | PDAC | 7(6.5) | Yes | Yes | Yes | 30d | 8 |
Hakeem | UK | OCS (R,S) | 2014 | 2005–2009 | 12 | 12 | PAAC | NR | NR | NR | Yes | 30d | 9 |
Chen | China | OCS (P,S) | 2015 | 2010–2013 | 19 | 38 | PDAC | 1(5.3) | Yes | Yes | Yes | NR | 8 |
Song | Korea | OCS (R,S) | 2015 | 2007–2012 | 11 | 261 | PDAC | NR | No | Yes | Yes | 30d | 8 |
Dokmak | France | OCS (P,S) | 2015 | 2011–2014 | 15 | 14 | PDAC | NR | Yes | Yes | Yes | 90d | 7 |
Stauffer | USA | OCS (P,S) | 2017 | 1995–2014 | 58 | 193 | PDAC | 14(24.1) | Yes | Yes | Yes | 90d | 8 |
Kantor | USA | OCS (R,M) | 2017 | 2010–2013 | 828 | 7385 | PDAC | E | NR | NR | NR | 90d | 8 |
Conrad | USA | OCS (P,S) | 2017 | 2000–2010 | 40 | 25 | Mixed | 9(18.4)a | No | Yes | Yes | 90d | 9 |
Palanivelu | India | RCT | 2017 | 2013–2015 | 32 | 32 | Mixed | 1(3.1) | Yes | Yes | Yes | 90d | 3a |
Khaled | UK | OCS (R,S) | 2017 | 2002–2015 | 15 | 15 | Mixed | 1(6.7) | Yes | Yes | Yes | 30d | 9 |
Meng | China | OCS (R,S) | 2018 | 2010–2015 | 58 | 58 | PAAC | NR | NR | Yes | Yes | 30d | 9 |